Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL3623290 (Azd 3759, Azd-3759, Azd3759, AZD3759, Zorifertinib) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
D2 receptor/Dopamine D2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL217] [GtoPdb: 215] [UniProtKB: P14416] | ||||||||
ChEMBL | Inhibition of recombinant D2 receptor (unknown origin) | B | 6.1 | pIC50 | 797 | nM | IC50 | J Med Chem (2015) 58: 8200-8215 [PMID:26313252] |
epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
ChEMBL | Inhibition of EGFR (unknown origin) by HTRF assay in presence of 2 mM of ATP | B | 6.99 | pIC50 | 102 | nM | IC50 | J Med Chem (2015) 58: 8200-8215 [PMID:26313252] |
ChEMBL | Inhibition of EGFR phosphorylation in human H838 cells | B | 7.19 | pIC50 | 64.5 | nM | IC50 | J Med Chem (2015) 58: 8200-8215 [PMID:26313252] |
ChEMBL | Inhibition of EGFR L858R mutant (unknown origin) by HTRF assay in presence of 2 mM of ATP | B | 8.12 | pIC50 | 7.6 | nM | IC50 | J Med Chem (2015) 58: 8200-8215 [PMID:26313252] |
ChEMBL | Inhibition of EGFR exon19 deletion mutant phosphorylation in human PC9 cells | B | 8.13 | pIC50 | 7.4 | nM | IC50 | J Med Chem (2015) 58: 8200-8215 [PMID:26313252] |
GtoPdb | Inhibition of EGFRL858R in vitro. | - | 8.14 | pIC50 | 7.2 | nM | IC50 | J Med Chem (2015) 58: 8200-15 [PMID:26313252] |
ChEMBL | Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells | B | 8.14 | pIC50 | 7.2 | nM | IC50 | J Med Chem (2015) 58: 8200-8215 [PMID:26313252] |
ChEMBL | Inhibition of EGFR exon19 deletion mutant (unknown origin) by HTRF assay in presence of 2mM of ATP | B | 8.62 | pIC50 | 2.4 | nM | IC50 | J Med Chem (2015) 58: 8200-8215 [PMID:26313252] |
ChEMBL | Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay | B | 9.3 | pIC50 | <0.5 | nM | IC50 | ACS Med Chem Lett (2019) 10: 22-26 [PMID:30655941] |
GtoPdb | Inhibition of wild type EGFR in vitro, at Km of ATP. | - | 9.52 | pIC50 | 0.3 | nM | IC50 | J Med Chem (2015) 58: 8200-15 [PMID:26313252] |
ChEMBL | Inhibition of EGFR (unknown origin) by HTRF assay in presence of Km of ATP | B | 9.52 | pIC50 | 0.3 | nM | IC50 | J Med Chem (2015) 58: 8200-8215 [PMID:26313252] |
ChEMBL | Inhibition of EGFR L858R mutant (unknown origin) by HTRF assay in presence of Km of ATP | B | 9.7 | pIC50 | 0.2 | nM | IC50 | J Med Chem (2015) 58: 8200-8215 [PMID:26313252] |
ChEMBL | Inhibition of EGFR exon19 deletion mutant (unknown origin) by HTRF assay in presence of Km of ATP | B | 9.7 | pIC50 | 0.2 | nM | IC50 | J Med Chem (2015) 58: 8200-8215 [PMID:26313252] |
SRC proto-oncogene, non-receptor tyrosine kinase/Tyrosine-protein kinase SRC in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL267] [GtoPdb: 2206] [UniProtKB: P12931] | ||||||||
ChEMBL | Inhibition of recombinant Src (unknown origin) after 40 mins by scintillation counting analysis in presence of [gamma33P]-ATP | B | 6.21 | pIC50 | 622 | nM | IC50 | J Med Chem (2015) 58: 8200-8215 [PMID:26313252] |
kinase insert domain receptor/Vascular endothelial growth factor receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL279] [GtoPdb: 1813] [UniProtKB: P35968] | ||||||||
ChEMBL | Inhibition of recombinant KDR (unknown origin) after 40 mins by scintillation counting analysis in presence of [gamma33P]-ATP | B | 6.81 | pIC50 | 156 | nM | IC50 | J Med Chem (2015) 58: 8200-8215 [PMID:26313252] |
Kv11.1 in Human [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
GtoPdb | Channel inhibition measured in a conventional manual whole-cell patch clamp study. | - | 4.88 | pIC50 | 13300 | nM | IC50 | J Med Chem (2015) 58: 8200-15 [PMID:26313252] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]